On October 29, 2025, Genenta Science S.p.A. held a shareholders’ meeting where they approved amendments to expand the company's corporate purpose, increased the Board of Directors from three to five members, and appointed two new directors with an annual compensation of €60,000. The effectiveness of the by-law amendment is conditional on no shareholders exercising their withdrawal rights before November 15, 2025.